Skip to content

Lifecore Biomedical, Inc. LFCR Finance Lease Liabilities (Total)

Finance Lease Liabilities (Total) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$213M+6.5%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$10.63M-63.4%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$4.8M+14.3%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$2.41M-41.4%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s finance lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s finance lease liabilities (total)?
Lifecore Biomedical, Inc. (LFCR) reported finance lease liabilities (total) of $5.83M in Q1 2026.
How has Lifecore Biomedical, Inc.'s finance lease liabilities (total) changed year-over-year?
Lifecore Biomedical, Inc.'s finance lease liabilities (total) decreased by 2.2% year-over-year, from $5.97M to $5.83M.
What is the long-term trend for Lifecore Biomedical, Inc.'s finance lease liabilities (total)?
Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s finance lease liabilities (total) has grown at a 11.2% compound annual growth rate (CAGR), from $3.43M to $5.83M.
What does finance lease liabilities (total) mean?
Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.